CTXR - Citius Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CTXR is currently covered by 2 analysts with an average price target of $6.21. This is a potential upside of $3.59 (137.02%) from yesterday's end of day stock price of $2.62.

Citius Pharmaceuticals's activity chart (see below) currently has 6 price targets and 18 ratings on display. The stock rating distribution of CTXR is 91.67% BUY and 8.33% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 27.78% with an average time for these price targets to be met of 113 days.

Highest price target for CTXR is $9, Lowest price target is $4, average price target is $6.21.

Most recent stock forecast was given by JASON KOLBERT from BENCHMARK on 07-Jan-2025. First documented stock forecast 23-May-2018.

Best performing analysts who are covering CTXR - Citius Pharmaceuticals:

Vernon Bernardino Michael Okunewitch Jason Kolbert

Currently out of the existing stock ratings of CTXR, 11 are a BUY (91.67%), 1 are a HOLD (8.33%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$9

$6.33 (237.08%)

$9

1 months 5 days ago
(07-Jan-2025)

0/9 (0%)

$4.87 (117.92%)

Buy

$4

$1.33 (49.81%)

$4

3 months ago
(12-Nov-2024)

5/6 (83.33%)

$3.5 (700.00%)

339

Buy

$4

$3.32 (488.24%)

3 years 2 months 12 days ago
(01-Dec-2021)

0/1 (0%)

$2.4 (150.00%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CTXR (Citius Pharmaceuticals) average time for price targets to be met?

On average it took 113 days on average for the stock forecasts to be realized with a an average price target met ratio 27.78

Which analyst has the current highest performing score on CTXR (Citius Pharmaceuticals) with a proven track record?

VERNON BERNARDINO

Which analyst has the current lower performing score on CTXR (Citius Pharmaceuticals) with a proven track record?

JASON KOLBERT

Which analyst has the most public recommendations on CTXR (Citius Pharmaceuticals)?

Vernon Bernardino has 11 price targets and 8 ratings on CTXR

Which analyst is the currently most bullish on CTXR (Citius Pharmaceuticals)?

Jason Kolbert with highest potential upside - $6.33

Which analyst is the currently most reserved on CTXR (Citius Pharmaceuticals)?

Vernon Bernardino with lowest potential downside - $1.33

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?